Global Health Technologies Coalition Global Health Technologies Coalition
  • Why R&D
  • R&D Facts
  • In Your State
  • Solutions
  • Breakthroughs Blog
  • News & Events
  • Resources
  • About Us
Stay Informed

Global health R&D delivers forSouth Dakota

Map
South Dakota
Select a new state
Select a State
Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois
Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana
Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island
South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

US government investment in global health R&D has delivered

$1.2 million
to South Dakota research institutions
South Dakota

Neglected diseases in South Dakota

Chikungunya cases
Chikungunya cases
2
Dengue cases
Dengue cases
10
HIV diagnoses
HIV diagnoses
250
Malaria cases
Malaria cases
24
Tuberculosis cases
Tuberculosis cases
129
West Nile cases
West Nile cases
683
Zika cases
Zika cases
3
South Dakota's top USG-funded global health R&D institutions

South Dakota's top USG-funded global health R&D institutions

South Dakota State University
$1.2 million
South Dakota industry in global health R&D

South Dakota industry in global health R&D

Auratus Bio
Location(s): Canton
Medgene Labs
Location(s): Brookings
SAB Biotherapeutics
Location(s): Sioux Falls

South Dakota's top areas of global health R&D by USG funding

66.6%
Malaria
33.4%
Diarrheal diseases
Global health R&D at work in South Dakota
Global health R&D at work in South Dakota

Researchers at South Dakota State University are part of a consortium of global organizations working to develop a vaccine against enterotoxigenic E. coli, or ETEC, a deadly diarrheal disease. The scientists altered the toxins produced by a form of E. coli and genetically fused this non-poisonous "toxoid" to a protein known to evoke an immune response. The resulting "fusion protein" could be used to develop a vaccine. Besides causing diarrheal illness in farm animals, ETEC is a main source of bacterial-induced diarrhea in low-income countries and is the chief cause of traveler's diarrhea. Unsafe water sources and lack of adequate sanitation increase the risk of contracting ETEC. The World Health Organization estimates that ETEC causes approximately 210 million cases of illness in humans and 380,000 deaths each year, most of whom are young children.

Download PDF
Map
Select a new state
Footnotes
  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Case study photo: PATH/Aaron Joel Santos
Close
advancing innovation to save lives

© 2009–2021, PATH, as secretariat of the Global Health Technologies Coalition.

Site managed by A3CS

  • Stay Informed
  • Join Us
  • Contact Us
  • GHTC Member Log In